The contribution of NFκB signaling to the initiation and progression of cancer is clearly documented, and several lines of evidence demonstrate that TNF-α and/or NFκB signaling plays a key role in the regulation of EMT [8], [9], [10]. The gene discussed is TNF; the disease is cancer.